Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections

References

• Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. doi:10.1038/s41564-020-0695-z
   PubMed Web of Science ®Google Scholar
• Schultheiss C, Paschold L, Simnica D, et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020;53:442–455. doi:10.1016/j.immuni.2020.06.024
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Gupta KK, Khan MA, Singh SK. Constitutive inflammatory cytokine storm: a major threat to human health. J Interferon Cytokine Res. 2020;40:19–23. doi:10.1089/jir.2019.0085
   PubMed Web of Science ®Google Scholar
• Cepeda-Valdes R, Carrion-Alvarez D, Trejo-Castro A, et al. Cutaneous manifestations in COVID-19: familial cluster of urticarial rash. Clin Exp Dermatol. 2020;45:895–896. doi:10.1111/ced.14290
   PubMed Web of Science ®Google Scholar
• Fajgenbaum DC, June CH, Longo DL. Cytokine Storm. N Engl J Med. 2020;383:2255–2273. doi:10.1056/NEJMra2026131
   PubMed Web of Science ®Google Scholar
• Moller AS, Ovstebo R, Haug KB, et al. Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs). Cytokine. 2005;32:304–315. doi:10.1016/j.cyto.2005.11.008
   PubMed Web of Science ®Google Scholar
• Thompson MR, Kaminski JJ, Kurt-Jones EA, et al. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3:920–940. doi:10.3390/v3060920
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Historical insights into cytokines. Eur J Immunol. 2007;37(Suppl1):S34–S45. doi:10.1002/eji.200737772
   PubMed Web of Science ®Google Scholar
• Tavakolpour S, Mahmoudi H, Mirzazadeh A, et al. Pathogenic and protective roles of cytokines in pemphigus: a systematic review. Cytokine. 2020;129:155026. doi:10.1016/j.cyto.2020.155026
   PubMed Web of Science ®Google Scholar
• Yen YT, Liao F, Hsiao CH, et al. Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol. 2006;80:2684–2693. doi:10.1128/JVI.80.6.2684-2693.2006
   PubMed Web of Science ®Google Scholar
• Wei YZBF. Aberrant Pathogenic GM-CSF+ T Cells and Inflammatory CD14+CD16+ Monocytes in Severe Pulmonary Syndrome Patients of a New Coronavirus (Published February 20, 2020). Atlanta: NewsRx; 2020.
   Google Scholar
• Woo PCY, Lau SKP, Lam CSF, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86:3995–4008.
   PubMed Web of Science ®Google Scholar
• Pal M, Berhanu G, Desalegn C, et al. Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020;12:e7423.
   PubMed Web of Science ®Google Scholar
• Pellett PE, Mitra S, Holland TC. Basics of virology. Handb Clin Neurol. 2014;123:45–66.
   PubMedGoogle Scholar
• Zhu Z, Lian X, Su X, et al. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. 2020;21:224. doi:10.1186/s12931-020-01479-w
   PubMed Web of Science ®Google Scholar
• Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130–137. doi:10.1111/resp.13196
   PubMed Web of Science ®Google Scholar
• Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of Coronaviruses. Trends Microbiol. 2016;24:490–502. doi:10.1016/j.tim.2016.03.003
   PubMed Web of Science ®Google Scholar
• Forni D, Cagliani R, Clerici M, et al. Molecular evolution of human coronavirus genomes. Trends Microbiol. 2017;25:35–48. doi:10.1016/j.tim.2016.09.001
   PubMed Web of Science ®Google Scholar
• Qian Z, Travanty EA, Oko L, et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013;48:742–748. doi:10.1165/rcmb.2012-0339OC
   PubMed Web of Science ®Google Scholar
• Cheung CY, Poon LL, Ng IH, et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005;79:7819–7826. doi:10.1128/JVI.79.12.7819-7826.2005
   PubMed Web of Science ®Google Scholar
• Law HKW, Cheung CY, Ng HY, et al. Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells. Blood. 2005;106:2366–2374. doi:10.1182/blood-2004-10-4166
   PubMed Web of Science ®Google Scholar
• Chien JY, Hsueh PR, Cheng WC, et al. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology. 2006;11:715–722. doi:10.1111/j.1440-1843.2006.00942.x
   PubMed Web of Science ®Google Scholar
• Wang CH, Liu CY, Wan YL, et al. Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respir Res. 2005;6:42. doi:10.1186/1465-9921-6-42
   PubMed Web of Science ®Google Scholar
• Wong CK, Lam CWK, Wu AKL, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95–103. doi:10.1111/j.1365-2249.2004.02415.x
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251–254. doi:10.1038/nature12005
   PubMed Web of Science ®Google Scholar
• Cha RH, Joh JS, Jeong I, et al. Renal complications and their prognosis in Korean patients with middle east respiratory syndrome-Coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci. 2015;30:1807–1814. doi:10.3346/jkms.2015.30.12.1807
   PubMed Web of Science ®Google Scholar
• Khalid I, Alraddadi BM, Dairi Y, et al. Acute management and long-term survival among subjects with severe middle east respiratory syndrome Coronavirus pneumonia and ARDS. Respir Care. 2016;61:340–348. doi:10.4187/respcare.04325
   PubMed Web of Science ®Google Scholar
• Lau SKP, Lau CCY, Chan K, et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013;94:2679–2690. doi:10.1099/vir.0.055533-0
   PubMed Web of Science ®Google Scholar
• Zhou J, Chu H, Li C, et al. Active replication of middle east respiratory syndrome Coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis. 2014;209:1331–1342. doi:10.1093/infdis/jit504
   PubMed Web of Science ®Google Scholar
• Tynell J, Westenius V, Ronkko E, et al. Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. J Gen Virol. 2016;97:344–355. doi:10.1099/jgv.0.000351
   PubMed Web of Science ®Google Scholar
• Chu H, Zhou J, Wong BH, et al. Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016;213:904–914. doi:10.1093/infdis/jiv380
   PubMed Web of Science ®Google Scholar
• Scheuplein VA, Seifried J, Malczyk AH, et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of middle east respiratory syndrome Coronavirus. J Virol. 2015;89:3859–3869. doi:10.1128/JVI.03607-14
   PubMed Web of Science ®Google Scholar
• Kim ES, Choe PG, Park WB, et al. Clinical progression and cytokine profiles of middle east respiratory syndrome Coronavirus infection. J Korean Med Sci. 2016;31:1717. doi:10.3346/jkms.2016.31.11.1717
   PubMed Web of Science ®Google Scholar
• Min C, Cheon S, Ha N, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016;6:25359. doi:10.1038/srep25359
   PubMed Web of Science ®Google Scholar
• Abassi Z, Knaney Y, Karram T, et al. The lung macrophage in SARS-CoV-2 infection: a friend or a foe? Front Immunol. 2020;11. doi:10.3389/fimmu.2020.01312
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846–848. doi:10.1007/s00134-020-05991-x
   PubMed Web of Science ®Google Scholar
• Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761–1766. doi:10.1016/S0140-6736(03)13410-1
   PubMed Web of Science ®Google Scholar
• Baharoon S, Memish ZA. MERS-CoV as an emerging respiratory illness: a review of prevention methods. Travel Med Infect Dis. 2019;32:101520. doi:10.1016/j.tmaid.2019.101520
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. doi:10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Chan JF-W, Yuan S, Kok K-H. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi:10.1016/S0140-6736(20)30154-9
   PubMed Web of Science ®Google Scholar
• Wan S, Yi Q, Fan S, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv. 2020;2020–2022. doi:10.1101/2020.02.10.20021832
   Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Zhao Y, Qin L, Zhang P, et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020;5:e139834. doi:10.1172/jci.insight.139834
   PubMed Web of Science ®Google Scholar
• Wang X, Xu W, Hu G, et al. RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020;17:894. doi:10.1038/s41423-020-0498-4
   PubMed Web of Science ®Google Scholar
• National Research Project for SARS. The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome. Am J Clin Pathol. 2004;121:507–511. doi:10.1309/WPK7Y2XKNF4CBF3R
   PubMed Web of Science ®Google Scholar
• Alosaimi B, Hamed ME, Naeem A, et al. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Cytokine. 2020;126:154895. doi:10.1016/j.cyto.2019.154895
   PubMed Web of Science ®Google Scholar
• Matic S, Popovic S, Djurdjevic P, et al. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets. PLoS One. 2020;15:e241097. doi:10.1371/journal.pone.0241097
   Web of Science ®Google Scholar
• Wang W, Su B, Pang L, et al. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients. Cell Mol Immunol. 2020;17:650–652. doi:10.1038/s41423-020-0447-2
   PubMed Web of Science ®Google Scholar
• Beniac DR, Andonov A, Grudeski E, et al. Architecture of the SARS coronavirus prefusion spike. Nat Struct Mol Biol. 2006;13:751–752. doi:10.1038/nsmb1123
   PubMed Web of Science ®Google Scholar
• Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3:237–261. doi:10.1146/annurev-virology-110615-042301
   PubMed Web of Science ®Google Scholar
• Neuman BW, Kiss G, Kunding AH, et al. A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol. 2011;174:11–22. doi:10.1016/j.jsb.2010.11.021
   PubMed Web of Science ®Google Scholar
• Nieto-Torres JL, Dediego ML, Verdia-Baguena C, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014;10:e1004077. doi:10.1371/journal.ppat.1004077
   PubMed Web of Science ®Google Scholar
• Dediego ML, Alvarez E, Almazan F, et al. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol. 2007;81:1701–1713. doi:10.1128/JVI.01467-06
   PubMed Web of Science ®Google Scholar
• Huang Y, Yang C, Xu XF, et al. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41:1141–1149. doi:10.1038/s41401-020-0485-4
   PubMed Web of Science ®Google Scholar
• Hulswit RJ, de Haan CA, Bosch BJ. Coronavirus spike protein and tropism changes. Adv Virus Res. 2016;96:29–57.
   PubMed Web of Science ®Google Scholar
• Verdia-Baguena C, Nieto-Torres JL, Alcaraz A, et al. Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. Virology. 2012;432:485–494. doi:10.1016/j.virol.2012.07.005
   PubMed Web of Science ®Google Scholar
• Malik YA. Properties of Coronavirus and SARS-CoV-2. Malays J Pathol. 2020;42:3–11.
   PubMed Web of Science ®Google Scholar
• Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–236. doi:10.1080/22221751.2020.1719902
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Surya W, Li Y, Verdia-Baguena C, et al. MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels. Virus Res. 2015;201:61–66. doi:10.1016/j.virusres.2015.02.023
   PubMed Web of Science ®Google Scholar
• Ujike M, Taguchi F. Incorporation of spike and membrane glycoproteins into coronavirus virions. Viruses. 2015;7:1700–1725. doi:10.3390/v7041700
   PubMed Web of Science ®Google Scholar
• Wang N, Li SY, Yang XL, et al. Serological evidence of bat SARS-related Coronavirus infection in Humans, China. Virol Sin. 2018;33:104–107. doi:10.1007/s12250-018-0012-7
   PubMed Web of Science ®Google Scholar
• Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the Novel Coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325–328. doi:10.1016/j.chom.2020.02.001
   PubMed Web of Science ®Google Scholar
• Shi CS, Nabar NR, Huang NN, et al. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5:101. doi:10.1038/s41420-019-0181-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen Y, Li Y, et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι. Proc Natl Acad Sci U S A. 2021;118:e2024202118. doi:10.1073/pnas.2024202118
   PubMed Web of Science ®Google Scholar
• Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53:368–370. doi:10.1016/j.jmii.2020.03.005
   PubMedGoogle Scholar
• Fung TS, Huang M, Liu DX. Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions. Virus Res. 2014;194:110–123. doi:10.1016/j.virusres.2014.09.016
   PubMed Web of Science ®Google Scholar
• Favreau DJ, Meessen-Pinard M, Desforges M, et al. Human coronavirus-induced neuronal programmed cell death is cyclophilin d dependent and potentially caspase dispensable. J Virol. 2012;86:81–93. doi:10.1128/JVI.06062-11
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takeda K. Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract. 2010;2010:1–8. doi:10.1155/2010/240365
   Web of Science ®Google Scholar
• Mahla RS, Reddy MC, Prasad DVR, et al. Sweeten PAMPs: role of sugar complexed PAMPs in innate immunity and vaccine biology. Front Immunol. 2013;4:248. doi:10.3389/fimmu.2013.00248
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Oshiumi H, Seya T. Antiviral responses induced by the TLR3 pathway. Rev Med Virol. 2011;21:67–77. doi:10.1002/rmv.680
   PubMed Web of Science ®Google Scholar
• Gay NJ, Symmons MF, Gangloff M, et al. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014;14:546–558. doi:10.1038/nri3713
   PubMed Web of Science ®Google Scholar
• Yang C, Chen M. Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity. PeerJ. 2021;9:e11008. doi:10.7717/peerj.11008
   PubMed Web of Science ®Google Scholar
• Moreno-Eutimio MA, López-Macías C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect. 2020;22:226–229. doi:10.1016/j.micinf.2020.04.009
   PubMed Web of Science ®Google Scholar
• Cicco S, Cicco G, Racanelli V, et al. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): two potential targets for COVID-19 treatment. Mediators Inflamm. 2020;2020:1–25. doi:10.1155/2020/7527953
   Web of Science ®Google Scholar
• Onofrio L, Caraglia M, Facchini G, et al. Toll-like receptors and COVID-19: a two-faced story with an exciting ending. Future Sci OA. 2020;6:FSO605. doi:10.2144/fsoa-2020-0091
   PubMed Web of Science ®Google Scholar
• Choudhury A, Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs. J Med Virol. 2020;92:2105–2113. doi:10.1002/jmv.25987
   PubMed Web of Science ®Google Scholar
• Birra D, Benucci M, Landolfi L, et al. COVID 19: a clue from innate immunity. Immunol Res. 2020;68:161–168. doi:10.1007/s12026-020-09137-5
   PubMed Web of Science ®Google Scholar
• Mizutani T. Signal transduction in SARS-CoV-infected cells. Ann N Y Acad Sci. 2007;1102:86–95. doi:10.1196/annals.1408.006
   PubMed Web of Science ®Google Scholar
• Frieman M, Ratia K, Johnston RE, et al. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol. 2009;83:6689–6705. doi:10.1128/JVI.02220-08
   PubMed Web of Science ®Google Scholar
• Siu KL, Kok KH, Ng MJ, et al. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem. 2009;284:16202–16209. doi:10.1074/jbc.M109.008227
   PubMed Web of Science ®Google Scholar
• Alfuwaires M, Altaher A, Kandeel M. Molecular dynamic studies of interferon and innate immunity resistance in MERS CoV non-structural protein 3. Biol Pharm Bull. 2017;40:345–351. doi:10.1248/bpb.b16-00870
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang L, Geng H, et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell. 2013;4:951–961. doi:10.1007/s13238-013-3096-8
   PubMed Web of Science ®Google Scholar
• Xia H, Cao Z, Xie X, et al. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi:10.1016/j.celrep.2020.108234
   PubMed Web of Science ®Google Scholar
• Lei X, Dong X, Ma R, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11:3810. doi:10.1038/s41467-020-17665-9
   PubMed Web of Science ®Google Scholar
• Konno Y, Kimura I, Uriu K, et al. SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Rep. 2020;32:108185. doi:10.1016/j.celrep.2020.108185
   PubMed Web of Science ®Google Scholar
• Mu J, Fang Y, Yang Q, et al. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2. Cell Discov. 2020;6:65. doi:10.1038/s41421-020-00208-3
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhuang MW, Han L, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. Signal Transduct Target Ther. 2020;5:299. doi:10.1038/s41392-020-00438-7
   PubMed Web of Science ®Google Scholar